Choi YH - Search Results

1

Higher plasma bilirubin predicts veno-occlusive disease in early childhood undergoing hematopoietic stem cell transplantation with cyclosporine.

Kim KS, Moon A, Kang HJ, Shin HY, Choi YH, Kim HS, Kim SG. Kim KS, et al. Among authors: choi yh. World J Transplant. 2016 Jun 24;6(2):403-10. doi: 10.5500/wjt.v6.i2.403. World J Transplant. 2016. PMID: 27358786 Free PMC article.

2

Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases.

Choi YH, Han CY, Kim KS, Kim SG. Choi YH, et al. Toxicol Res. 2019 Oct;35(4):319-330. doi: 10.5487/TR.2019.35.4.319. Epub 2019 Oct 15. Toxicol Res. 2019. PMID: 31636843 Free PMC article. Review.

3

Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting.

Kim KS, Choi YH, Moon A, Kim SG. Kim KS, et al. Among authors: choi yh. J Clin Med. 2020 Feb 7;9(2):461. doi: 10.3390/jcm9020461. J Clin Med. 2020. PMID: 32046138 Free PMC article.

4

Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis.

Choi YH, Lee CH, Ko MS, Han HJ, Kim SG. Choi YH, et al. Toxicol Res. 2017 Oct;33(4):343-350. doi: 10.5487/TR.2017.33.4.343. Epub 2015 Oct 15. Toxicol Res. 2017. PMID: 29071019 Free PMC article.

5

Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.

Choi YH, Kim SG, Lee MG. Choi YH, et al. J Pharm Sci. 2006 Nov;95(11):2543-52. doi: 10.1002/jps.20744. J Pharm Sci. 2006. PMID: 16937336

6

Drug-induced hyperbilirubinemia and the clinical influencing factors.

Ah YM, Kim YM, Kim MJ, Choi YH, Park KH, Son IJ, Kim SG. Ah YM, et al. Among authors: choi yh. Drug Metab Rev. 2008;40(4):511-37. doi: 10.1080/03602530802341133. Drug Metab Rev. 2008. PMID: 18821100 Review.

7

Tacrolimus therapy causes hepatotoxicity in patients with a history of liver disease.

Ko MS, Choi YH, Jung SH, Lee JS, Kim HS, Lee CH, Kim SG. Ko MS, et al. Among authors: choi yh. Int J Clin Pharmacol Ther. 2015 May;53(5):363-71. doi: 10.5414/CP202226. Int J Clin Pharmacol Ther. 2015. PMID: 25740263

8

SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis.

Shin SY, Kim TH, Wu H, Choi YH, Kim SG. Shin SY, et al. Among authors: choi yh. Eur J Pharmacol. 2014 Mar 15;727:115-24. doi: 10.1016/j.ejphar.2014.01.035. Epub 2014 Jan 30. Eur J Pharmacol. 2014. PMID: 24486702

9

Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor.

Jang YP, Kim SR, Choi YH, Kim J, Kim SG, Markelonis GJ, Oh TH, Kim YC. Jang YP, et al. Among authors: choi yh. J Neurosci Res. 2002 Apr 15;68(2):233-40. doi: 10.1002/jnr.10204. J Neurosci Res. 2002. PMID: 11948668

10

Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.

Kim TH, Yang YM, Han CY, Koo JH, Oh H, Kim SS, You BH, Choi YH, Park TS, Lee CH, Kurose H, Noureddin M, Seki E, Wan YY, Choi CS, Kim SG. Kim TH, et al. Among authors: choi cs, choi yh. J Clin Invest. 2018 Dec 3;128(12):5587-5602. doi: 10.1172/JCI97831. Epub 2018 Nov 12. J Clin Invest. 2018. PMID: 30300140 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,572 results

Search Page

Filters